Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies

A Shao, S Tu, J Lu, J Zhang - Stem cell research & therapy, 2019 - Springer
The injured spinal cord is difficult to repair and regenerate. Traditional treatments are not
effective. Stem cells are a type of cells that have the potential to differentiate into various …

Spinal cord injuries: how could cell therapy help?

A Badner, AM Siddiqui, MG Fehlings - Expert opinion on biological …, 2017 - Taylor & Francis
Introduction: Spinal cord injury (SCI) is a devastating condition, where regenerative failure
and cell loss lead to paralysis. The heterogeneous and time-sensitive pathophysiology has …

Genome-wide characterization of the routes to pluripotency

SMI Hussein, MC Puri, PD Tonge, M Benevento… - Nature, 2014 - nature.com
Somatic cell reprogramming to a pluripotent state continues to challenge many of our
assumptions about cellular specification, and despite major efforts, we lack a complete …

Divergent reprogramming routes lead to alternative stem-cell states

PD Tonge, AJ Corso, C Monetti, SMI Hussein, MC Puri… - Nature, 2014 - nature.com
Pluripotency is defined by the ability of a cell to differentiate to the derivatives of all the three
embryonic germ layers: ectoderm, mesoderm and endoderm. Pluripotent cells can be …

Integrated genomic analysis of diverse induced pluripotent stem cells from the progenitor cell biology consortium

N Salomonis, PJ Dexheimer, L Omberg, R Schroll… - Stem cell reports, 2016 - cell.com
The rigorous characterization of distinct induced pluripotent stem cells (iPSC) derived from
multiple reprogramming technologies, somatic sources, and donors is required to …

Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells

HY Choi, TJ Lee, GM Yang, J Oh, J Won, J Han… - Journal of Controlled …, 2016 - Elsevier
Clinical applications of induced pluripotent stem cells (iPSCs) require development of
technologies for the production of “footprint-free”(gene integration-free) iPSCs, which avoid …

[HTML][HTML] Deciphering the roadmap of in vivo reprogramming toward pluripotency

D Chondronasiou, JM de Villarreal, E Melendez… - Stem Cell Reports, 2022 - cell.com
Differentiated cells can be converted into pluripotent stem cells by expressing the
transcription factors OCT4, SOX2, KLF4, and MYC (OSKM) in a process known as …

Creating patient-specific neural cells for the in vitro study of brain disorders

KJ Brennand, MC Marchetto, N Benvenisty, O Brüstle… - Stem cell reports, 2015 - cell.com
As a group, we met to discuss the current challenges for creating meaningful patient-specific
in vitro models to study brain disorders. Although the convergence of findings between …

Garlic-derived natural polysulfanes as hydrogen sulfide donors: Friend or foe?

E Yagdi, C Cerella, M Dicato, M Diederich - Food and Chemical Toxicology, 2016 - Elsevier
In vitro and in vivo studies reported the anti-cancer potential of organosulfur compounds
(OSCs) as they trigger biological effects leading to cell cycle arrest with accumulation of cells …

Nuclear microRNAs in normal hemopoiesis and cancer

JEJ Rasko, JJL Wong - Journal of hematology & oncology, 2017 - Springer
Since the discovery of microRNAs (miRNAs) in the early 1990s, these small molecules have
been increasingly recognized as key players in the regulation of critical biological …